2bkz

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|PDB= 2bkz |SIZE=350|CAPTION= <scene name='initialview01'>2bkz</scene>, resolution 2.60&Aring;
|PDB= 2bkz |SIZE=350|CAPTION= <scene name='initialview01'>2bkz</scene>, resolution 2.60&Aring;
|SITE= <scene name='pdbsite=AC1:So4+Binding+Site+For+Chain+D'>AC1</scene>
|SITE= <scene name='pdbsite=AC1:So4+Binding+Site+For+Chain+D'>AC1</scene>
-
|LIGAND= <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> and <scene name='pdbligand=SBC:1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE'>SBC</scene>
+
|LIGAND= <scene name='pdbligand=SBC:1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE'>SBC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>
-
|ACTIVITY= [http://en.wikipedia.org/wiki/Transferred_entry:_2.7.11.1 Transferred entry: 2.7.11.1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.37 2.7.1.37]
+
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span>
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2bkz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2bkz OCA], [http://www.ebi.ac.uk/pdbsum/2bkz PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2bkz RCSB]</span>
}}
}}
Line 21: Line 24:
Benzodipyrazoles: a new class of potent CDK2 inhibitors., D'Alessio R, Bargiotti A, Metz S, Brasca MG, Cameron A, Ermoli A, Marsiglio A, Polucci P, Roletto F, Tibolla M, Vazquez ML, Vulpetti A, Pevarello P, Bioorg Med Chem Lett. 2005 Mar 1;15(5):1315-9. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15713378 15713378]
Benzodipyrazoles: a new class of potent CDK2 inhibitors., D'Alessio R, Bargiotti A, Metz S, Brasca MG, Cameron A, Ermoli A, Marsiglio A, Polucci P, Roletto F, Tibolla M, Vazquez ML, Vulpetti A, Pevarello P, Bioorg Med Chem Lett. 2005 Mar 1;15(5):1315-9. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15713378 15713378]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
 +
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Transferred entry: 2 7.11 1]]
 
[[Category: Bargiottia, A.]]
[[Category: Bargiottia, A.]]
[[Category: Brasca, M G.]]
[[Category: Brasca, M G.]]
Line 36: Line 39:
[[Category: Vazquez, M L.]]
[[Category: Vazquez, M L.]]
[[Category: Vulpetti, A.]]
[[Category: Vulpetti, A.]]
-
[[Category: SBC]]
 
-
[[Category: SO4]]
 
[[Category: atp-binding]]
[[Category: atp-binding]]
[[Category: cell cycle]]
[[Category: cell cycle]]
Line 49: Line 50:
[[Category: transferase]]
[[Category: transferase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:03:20 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:07:55 2008''

Revision as of 23:07, 30 March 2008


PDB ID 2bkz

Drag the structure with the mouse to rotate
, resolution 2.60Å
Sites:
Ligands: ,
Activity: Non-specific serine/threonine protein kinase, with EC number 2.7.11.1
Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611


Overview

The synthesis and the preliminary expansion of this new class of CDK2 inhibitors are presented. The synthesis was accomplished using a solution-phase protocol amenable to rapid parallel expansion and suitable to be scaled-up in view of possible lead development. Following a medicinal chemistry program aimed at improving cell permeability and selectivity, a series of compounds with nanomolar activity in the biochemical assay and able to efficiently inhibit tumor cell proliferation has been obtained.

About this Structure

2BKZ is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Benzodipyrazoles: a new class of potent CDK2 inhibitors., D'Alessio R, Bargiotti A, Metz S, Brasca MG, Cameron A, Ermoli A, Marsiglio A, Polucci P, Roletto F, Tibolla M, Vazquez ML, Vulpetti A, Pevarello P, Bioorg Med Chem Lett. 2005 Mar 1;15(5):1315-9. PMID:15713378

Page seeded by OCA on Mon Mar 31 02:07:55 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools